Document ID: chunk:federal_register_of_legislation:C2023C00427:clause:2_5:p2
Version: federal_register_of_legislation:C2023C00427
Segment Type: clause
Provision Reference: sch 2 cl 5 (pt 2/2)
Character Range: 15256–16275

or a Medibank Private company of sale‑scheme hybrid securities;
 (m) an arrangement under which one or more designated companies (each of which is called a hybrid‑security issuer company) issue sale‑scheme hybrid securities;
 (n) the guarantee by the Commonwealth of obligations of a hybrid‑security issuer company in relation to sale‑scheme hybrid securities (for example, obligations to make payments of interest or dividends);
 (o) an agreement of the kind known as a securities lending arrangement, where the securities lending arrangement relates to shares in a Medibank Private company;
 (p) market stabilisation measures in relation to a Medibank Private company.
(7) In determining whether a scheme is a Medibank Private sale scheme, regard must be had to the economic and commercial substance of the scheme.
(8) Subitems (6) and (7) do not, by implication, limit subitem (2).

Definition
(9) In this item:
securities includes:
 (a) shares; and
 (b) debentures (within the meaning of the Corporations Act 2001).